BAX — BAXTER INTERNATIONAL INC

NYSE · Health Care · Health Care Equipment & Supplies · CIK 10456 ·
Last close
$24.77
Market Cap
$12.79B
52W High
$24.92
52W Low
$16.16
ADV30
6,136,530
Next earnings
2026-07-30
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 2,701,000,000 891,000,000 66,000,000 -15,000,000 19,846,000,000 2,017,000,000 13,830,000,000
Dec 2025 2,974,000,000 577,000,000 -244,000,000 -1,128,000,000 20,055,000,000 1,966,000,000 13,953,000,000
Sep 2025 2,835,000,000 950,000,000 172,000,000 -46,000,000 21,067,000,000 1,726,000,000 13,853,000,000
Jun 2025 2,810,000,000 991,000,000 191,000,000 91,000,000 21,046,000,000 1,686,000,000 13,753,000,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$1,263,000,000
Investing CF
$-473,000,000
Financing CF
$-1,001,000,000
CapEx
$-537,000,000
Dividends Paid
$-266,000,000
Buybacks
EPS Diluted TTM
$-2.13
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$13,685,000,000
Inventory
$2,316,000,000
Receivables
$1,698,000,000
ST Investments
EBIT TTM
$-221,000,000
Pretax Income TTM
$-508,000,000
Interest Exp TTM
$287,000,000
Analysts
13

Yahoo Snapshot (yfinance, live)

Total Revenue
$11,320,000,512
EBITDA
$1,908,999,936
Free Cash Flow
$900,875,008
Enterprise Value
$20,435,937,280
Total Cash
$2,016,999,936
Total Debt
$9,687,000,064
Shares Out
516,469,008
Trailing EPS
$-1.91
Book Value
$11.70
ROE
-15.0%
ROA
2.8%
Div Yield
0.82%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 11,244,000,000 177,000,000 -957,000,000 20,055,000,000 13,953,000,000 845,000,000
Dec 2024 10,636,000,000 439,000,000 -649,000,000 25,782,000,000 18,758,000,000 1,019,000,000
Dec 2023 10,360,000,000 707,000,000 2,656,000,000 28,276,000,000 19,808,000,000 1,726,000,000
Dec 2022 10,057,000,000 -33,000,000 -2,433,000,000 28,287,000,000 22,392,000,000 1,211,000,000

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$2.00

Max Pain — expiry 2026-08-21

max pain strike: $20.00 · spot: $24.77 · call oi: 7,670 · put oi: 3,689
Expected Move to 2026-08-21: ±$2.72 (10.98%) — implied range $22.05$27.49 · ATM straddle on $25.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
ALGN ALIGN TECHNOLOGY INC $12.90B $180.08
PEN Penumbra Inc $12.59B $320.13
SNNUF SMITH & NEPHEW PLC $13.24B $15.75
SNN SMITH & NEPHEW PLC $13.73B $32.66
PODD INSULET CORP $11.82B $170.62

News headlines (Yahoo Finance, 1h cache)

Baxter Reports Second-Quarter 2026 Results
2026-07-30 11:15 · Yahoo
Baxter Earnings: What To Look For From BAX
2026-07-29 16:05 · Yahoo
Watch These 4 Medical Product Stocks for Q2 Earnings: Beat or Miss?
2026-07-29 14:54 · Yahoo
Baxter (BAX) Stock May Be 19% Undervalued On Cash Flow
2026-07-29 12:09 · Yahoo
Why Baxter (BAX) Stock Is Up Today
2026-07-28 04:13 · Yahoo
3 Unprofitable Stocks That Fall Short
2026-07-27 22:45 · Yahoo
Will Baxter's Q2 Results Continue to Reflect Operational Headwinds?
2026-07-24 15:21 · Yahoo
Earnings Preview: Baxter International (BAX) Q2 Earnings Expected to Decline
2026-07-23 14:00 · Yahoo
1 S&P 500 Stock for Long-Term Investors and 2 We Find Risky
2026-07-22 10:38 · Yahoo
3 Reasons to Avoid BAX and 1 Stock to Buy Instead
2026-07-16 17:29 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.